[go: up one dir, main page]

AU2006259663A1 - Tubulin inhibitor and process for its preparation - Google Patents

Tubulin inhibitor and process for its preparation Download PDF

Info

Publication number
AU2006259663A1
AU2006259663A1 AU2006259663A AU2006259663A AU2006259663A1 AU 2006259663 A1 AU2006259663 A1 AU 2006259663A1 AU 2006259663 A AU2006259663 A AU 2006259663A AU 2006259663 A AU2006259663 A AU 2006259663A AU 2006259663 A1 AU2006259663 A1 AU 2006259663A1
Authority
AU
Australia
Prior art keywords
trifluoro
pyrazin
process according
phenyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006259663A
Other languages
English (en)
Inventor
Jay Thomas Afragola
David Michael Blum
Timothy John Doyle
Jean Schmid
Yanzhong Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37074929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2006259663(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of AU2006259663A1 publication Critical patent/AU2006259663A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2006259663A 2005-06-13 2006-06-08 Tubulin inhibitor and process for its preparation Abandoned AU2006259663A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US69001605P 2005-06-13 2005-06-13
US60/690,016 2005-06-13
US80278106P 2006-05-24 2006-05-24
US60/802,781 2006-05-24
PCT/US2006/022574 WO2006138180A1 (fr) 2005-06-13 2006-06-08 Inhibiteur de tubuline et sa methode de preparation

Publications (1)

Publication Number Publication Date
AU2006259663A1 true AU2006259663A1 (en) 2006-12-28

Family

ID=37074929

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006259663A Abandoned AU2006259663A1 (en) 2005-06-13 2006-06-08 Tubulin inhibitor and process for its preparation

Country Status (12)

Country Link
EP (1) EP1891052A1 (fr)
JP (1) JP2008543838A (fr)
AR (1) AR054392A1 (fr)
AU (1) AU2006259663A1 (fr)
BR (1) BRPI0612145A2 (fr)
CA (1) CA2610416A1 (fr)
GT (1) GT200600257A (fr)
MX (1) MX2007015718A (fr)
PE (1) PE20070114A1 (fr)
SV (1) SV2007002573A (fr)
TW (1) TW200716613A (fr)
WO (1) WO2006138180A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163060B2 (en) 2009-11-12 2015-10-20 R&D Biopharmaceuticals Gmbh Tubulin inhibitors
WO2014047257A2 (fr) * 2012-09-19 2014-03-27 The Trustees Of The University Of Pennsylvania Composés hétérocycliques et leur utilisation pour le traitement de tauopathies neurodégénératives
WO2017181974A1 (fr) * 2016-04-20 2017-10-26 苏州苏领生物医药有限公司 Composé hétérocyclique à cinq chaînons, procédé de préparation correspondant, composition pharmaceutique et utilisation
WO2019169111A1 (fr) 2018-03-02 2019-09-06 The Trustees Of The University Of Pennsylvania Composés de [1,2,4]triazolo[1,5-a]pyrimidine et utilisation de ces derniers dans la stabilisation de microtubules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0414700A (pt) * 2003-09-24 2006-11-14 Wyeth Corp 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer
MXPA06003207A (es) * 2003-09-24 2006-06-23 Wyeth Corp 5-arilpirimidinas como agentes anti-cancer.

Also Published As

Publication number Publication date
WO2006138180A1 (fr) 2006-12-28
EP1891052A1 (fr) 2008-02-27
GT200600257A (es) 2007-02-14
CA2610416A1 (fr) 2006-12-28
MX2007015718A (es) 2008-02-21
TW200716613A (en) 2007-05-01
BRPI0612145A2 (pt) 2010-10-19
JP2008543838A (ja) 2008-12-04
SV2007002573A (es) 2007-01-03
PE20070114A1 (es) 2007-02-03
AR054392A1 (es) 2007-06-20

Similar Documents

Publication Publication Date Title
KR101612642B1 (ko) 테노포비어 알라펜아미드 헤미푸마레이트
CN104024229B (zh) 三唑并嘧啶化合物的合成
EP0303697A1 (fr) Derives de la substance physiologiquement active k-252
US10287254B2 (en) Salts of a dihydroquinazoline derivative
JP7744358B2 (ja) 急性骨髄性白血病の再発を処置または阻害するための化合物
JP2018021072A (ja) 治療活性化合物およびそれらの使用方法
CN102361557A (zh) 制备阿格列汀的方法
US20230250087A1 (en) Solid forms of apol1 inhibitor and methods of using same
CN115141215A (zh) Kras g12d蛋白抑制剂和其用途
EA025863B1 (ru) Карбазолкарбоксамидные соединения
EP2889287A1 (fr) Dérivé de dolastatine-10, procédé pour le produire et composition de médicament anticancéreux le contenant
KR20060098368A (ko) 항암제로서의 6-[(치환된)페닐]트리아졸로피리미딘
US20240158404A1 (en) Modulators of alpha-1 antitrypsin
RU2656485C2 (ru) Дейтерированные соединения хиназолинона и содержащие их фармацевтические композиции
US7501423B2 (en) Tubulin inhibitor and process for its preparation
AU2006259663A1 (en) Tubulin inhibitor and process for its preparation
US7396835B2 (en) Process for the preparation of tubulin inhibitors
DE69813886T2 (de) Naphthalin derivate
JPH07242670A (ja) ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体及びこれを含有する循環器系疾患治療剤
KR20250019074A (ko) Rock 억제제 및 그의 용도
WO2025007743A1 (fr) Agonistes de sting et leurs utilisations
HK1165216A (en) Process for the preparation of alogliptin
HK1090377B (en) Process for the preparation of tubulin inhibitors

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period